FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025
DOI: 10.1016/j.bbadis.2024.167633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Xi Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: zdxuxi@zju.e…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, HMGA2 Protein, Forkhead Transcription Factors, S100 Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, Zhejiang Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ovarian cancer is the most common type of gynecological malignant tumor, with the highest mortality rate among female genital malignant tumors. In this study, we initially identified forkhead box F1 (FOXF1) as a potential prognostic biomarker of ovarian cancer through bioinformatics analysis. FOXF1 expression was higher in ovarian cancer tissue samples and served as an unfavorable prognostic factor. In vitro and in vivo experiments demonstrated that FOXF1 enhanced ovarian cancer cell migration and tumor dissemination. Chromatin immunoprecipitation-polymerase chain reaction and luciferase assays revealed that FOXF1 bound directly to the high-mobility group AT-hook 2 (HMGA2) promoter and significantly induced its transcriptional activity. Subsequent co-immunoprecipitation and mass spectrometry analyses demonstrated that HMGA2 stabilized S100 calcium-binding protein A6 (S100A6) protein through recruitment of the deubiquitinase, ubiquitin-specific peptidase 30 (USP30), thereby inhibiting S100A6 degradation. Rescue experiments further illustrated that FOXF1 induced ovarian cancer cell mobility in an HMGA2/S100A6-dependent manner. Additionally, FOXF1, HMGA2, USP30, and S100A6 were clinically relevant in patients with ovarian cancer. This is the first study to reveal the molecular mechanisms underlying FOXF1-mediated ovarian cancer metastasis and demonstrate that FOXF1 represents a potential therapeutic target in patients with metastatic ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: zdxuxi@zju.edu.cn.
- Central Laboratory, The Municipal Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China. Electronic address: gongcj@zju.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Electronic address: wangyunfeng0317@live.com.
- Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: yinzhidong@zju.edu.cn.
- Department of Pathology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: 2516427@zju.edu.cn.
- Center for Molecular Pathology, Department of Pathophysiology, Gannan Medical University, Ganzhou 341000, China. Electronic address: xuebiaowu2022@163.com.
Förderung
- Jiangxi Provincial Natural Science Foundation
- Zhejiang Province Natural Science Foundation
- National Natural Science Foundation of China
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Xu, X., Gong, C., Wang, Y., Yin, Z., Wang, X., Wu, X., Fang, Z., & Wei, S. (2025). FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167633
Vancouver
Xu X, Gong C, Wang Y, Yin Z, Wang X, Wu X, et al. FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2024.167633
BibTeX
@article{Xu2025,
author = {Xu, Xi and Gong, Chaoju and Wang, Yunfeng and Yin, Zhidong and Wang, Xiaogang and Wu, Xuebiao and Fang, Zejun and Wei, Shumei},
title = {FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
doi = {10.1016/j.bbadis.2024.167633}
}
EUVIMED